ARTICLE | Company News
CeNeS, Elan in pain relief venture
June 1, 2001 7:00 AM UTC
CeNeS Pharmaceuticals (LSE:CEN) and ELN will form a new CEN subsidiary to develop pain relief treatments based on CEN's morphine-6-glucuronide ( M6G) compounds and ELN's Medipad drug delivery technolo...